Should I Buy AUBN? AUBN 2026 Analysis

Should You Buy Auburn National Bancorporation Inc (AUBN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

24.620

1 Day change

-0.04%

52 Week Range

29.000

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: price is holding above the pivot (25.527) with a bullish trend structure (SMA_5 > SMA_20 > SMA_200) and improving momentum (MACD histogram > 0 and expanding).
Near-term path: statistical pattern read points to a small next-day dip risk (~-0.87%) but favors upside over 1 week (+4.51%) and 1 month (+6.28%), aligning with the bullish technical setup.
Tactical levels: support to watch is 25.53 (pivot) then 24.73 (S1); upside targets are 26.32 (R1) and 26.81 (R2).
Event timing: earnings are scheduled 2026-02-10 (After Hours), providing a clear near-term catalyst window.

Technical Analysis

Trend: Bullish (SMA_5 > SMA_20 > SMA_200), indicating a sustained uptrend across short/medium/long horizons.
Momentum: MACD histogram 0.0111 (above zero) and positively expanding → momentum is improving.
RSI: RSI_6 54.666 (neutral) → not overbought; still room for continuation if buyers step in.
Key levels: Pivot 25.527; Resistance 26.32 (R1) then 26.809 (R2); Support 24.734 (S1) then 24.245 (S2).

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Earnings upcoming (2026-02-10 After Hours): clear event-driven catalyst that can draw attention/liquidity.
- Recent operating momentum: 2025/Q4 showed double-digit revenue growth and EPS growth, supportive for sentiment.
- Market backdrop: pre-market S&P 500 is slightly positive (+0.11%), not a headwind this morning.

Neutral/Negative Catalysts

- No news flow in the last week: limited narrative/catalyst support outside the upcoming earnings event.
- Near-term statistical read: similar-pattern analysis implies a slightly negative next-day expectation (~-0.87%).
- No strong positioning signal: hedge funds and insiders flagged as Neutral, suggesting no visible accumulation trend.
- No congress trading data: no visibility from that channel on sentiment/flows.

Financial Performance

Latest quarter: 2025/Q4
Revenue: $8.467M, +19.09% YoY (strong top-line growth).
Net income: $1.665M, +6.73% YoY (positive but slower than revenue).
EPS: $0.48, +6.67% YoY (steady earnings growth).
Overall: growth is positive, with revenue accelerating faster than bottom-line growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target data provided, implying no observable recent upgrades/downgrades or target changes from the dataset.
Wall Street pro/con view (from available data): Pros = improving fundamentals (2025/Q4 growth) and bullish technical trend; Cons = limited external coverage/signals (no options/analyst data, no recent news catalysts until earnings).

Analyst Rating

Wall Street analysts forecast AUBN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AUBN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 24.630

Low

Averages

High